Back to ADMA BIOLOGICS, INC.

ADMA BIOLOGICS, INC. News

ADMA

ADMA Biologics Initiates $125M ASR Deal

ADMA Biologics (ADMA) initiated a $125M accelerated share repurchase on 2026-03-02. This follows a recent CFO transition and prior Q3 2025 update.

2 March 2026ADMA BIOLOGICS, INC.
ADMA

ADMA BIOLOGICS CFO Retirement — Terry Kohler Named

ADMA BIOLOGICS announces CFO Brad Tade's retirement and appoints Terry Kohler as CFO and Treasurer. Key facts and investor implications, Feb 25, 2026.

25 February 2026ADMA BIOLOGICS, INC.
ADMA

ADMA Q3 2025 Results & FDA Lot Release

ADMA Biologics Q3 2025: revenue up 12% and an FDA lot release boosts outlook. Key investor takeaways and context.

5 November 2025ADMA BIOLOGICS, INC.
All news